Clinical Study of Use of Remdesivir and Tocilizumab in Severely Ill COVID-19 Patients.

导出 LinkOut

翻译打印收藏纠错

作者： Vishal,Gupta ^[1] ; Sushrut,Ingawale ^[2] ; Amit,Bhondve ^[3] ; Wasim,Khot ^[4] ; Santosh,Salagre ^[5] ; Archana,Sonawale ^[6] ; Kavita,Joshi ^[1] ; Meghna,Vaidya ^[1] ; Smrati,Tiwari ^[1] ; Kaustubh,Salagre ^[1] ; Yogesh,Pawade ^[7] ; Juhi,Kawale ^[8] ; Nilakshi,Sabnis ^[8]

作者单位： Associate Professor, Seth GSMC KEMH, Mumbai, Maharashtra. ^[1] PGY-3 Resident, Department of General Medicine, Seth GSMC KEMH, Mumbai, Maharashtra; Corresponding Author. ^[2] Assistant Professor, Department of Community Medicine, Seth GSMC KEMH, Mumbai, Maharashtra. ^[3] Ex-Assistant Professor, Seth GSMC KEMH, Mumbai, Maharashtra. ^[4] Professor, Department of General Medicine, Seth GSMC KEMH, Mumbai, Maharashtra. ^[5] Associate Professor,Seth GSMC KEMH, Mumbai, Maharashtra. ^[6] Associate Professor, Department of Biochemistry, Seth GSMC KEMH, Mumbai, Maharashtra. ^[7] Assistant Professor, Department of General Medicine, Seth GSMC KEMH, Mumbai, Maharashtra. ^[8]

主题词腺苷一磷酸(Adenosine Monophosphate);丙氨酸(Alanine);人类(Humans);回顾性研究(Retrospective Studies)

DOI 10.0102/japi.2021.07

PMID 34431263

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交